Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Bastide le Confort Medical ( (FR:BLC) ) has issued an announcement.
Bastide Group has expanded its operations in Canada by obtaining authorization to operate in respiratory assistance in British Columbia, which could lead to a significant increase in revenue. Additionally, Bastide has sold its French subsidiary CICA PLUS, which was underperforming financially, as part of its strategy to divest low-growth assets and focus on reducing debt.
More about Bastide le Confort Medical
The Bastide Group, founded in 1977, is a leading European home health care provider operating in eight countries. It specializes in medical devices and services across various health areas including diabetes, nutrition, infusion, respiratory, stomatherapy, and urology. The company is listed on Euronext Paris.
YTD Price Performance: -4.55%
Average Trading Volume: 156
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €171M
For detailed information about BLC stock, go to TipRanks’ Stock Analysis page.
Trending Articles
- Metro Supermarkets (TSE:MRU) Adds New Hydration Drink
- Apple Settles $95M Class Action Suit and Clears Siri’s Privacy Norms
- Biden Plans One Last Chip Export Curb on Nvidia Before Leaving Office
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
